Rejuvenate Bio
Agent49Agent Readiness: 49/100. Top 25%. Measured by StartupHub.ai. Median 41.Trust68Data Trust: 68/100. Above median. Measured by StartupHub.ai. Median 61.Developing novel therapies to reverse aging and extend lifespan.
We may earn a commission from links on this Rejuvenate Bio profile. That does not change the facts we publish.
About
Rejuvenate Bio is a biotechnology company focused on developing novel therapies to reverse aging and extend lifespan. The company's approach leverages advancements in genetic engineering and regenerative medicine to target the fundamental mechanisms of aging. Their research aims to create treatments that can restore youthful function to tissues and organs, ultimately leading to healthier and longer lives for both humans and animals.
Listed competitors
Also in this space
Moderna is a biotechnology company pioneering mRNA medicine, best known for its COVID-19 vaccine and a broad pipeline of mRNA-based therapeutics.
Shares Biotechnology, Biotech
A life sciences company that has developed a high-throughput platform for mapping molecular cell architecture at nanoscale resolution.
Shares Biotechnology, Genomics
Epicrispr Biotechnologies is a biotechnology company developing novel epigenetic therapies, with a lead program targeting Facioscapulohumeral Muscular Dystrophy (FSHD).
Shares Biotechnology, Biotech
A vertically-integrated procurement platform for the life sciences industry.
Shares Biotechnology, Biotech
Developing human-derived antibodies for inflammatory diseases and cancer using AI and proprietary platforms.
Shares Biotechnology, HealthTech
Clinical-stage biopharmaceutical company leveraging a proprietary platform to discover and develop novel precision medicines from fungi.
Shares Biotechnology, Drug Discovery
Key facts
- Website
- rejuvenatebio.com
- Headquarters
- Cambridge, Massachusetts, USA
- Founded
- 2018
- Employees
- 16
- Total funding
- $6M (Financing)
- Business model
- B2B
Funding rounds
| Date | Round | Amount | Lead investors |
|---|---|---|---|
| 2 Jun 2026 | Financing | $6M |
Tech stack
Detected on rejuvenatebio.com, last scanned 29 Oct 2026. Run your own scan
- CMS / Builders
- Squarespace
- Email provider
- Microsoft 365
- Affiliate program
- Self-hosted affiliate
Rejuvenate Bio scores 39. Does yours?
That is its Ahrefs DR: the backlink strength of a domain, on the Ahrefs 0 to 100 scale. Paste your website and you get yours in about a minute.
5 reviews from Reddit gathered in one place
Rejuvenate Bio lands $4m CIRM grant for gene-therapy research.
Interview with Rejuvenate Bio CEO on liver-directed gene therapy program targeting FGF21 in dogs and humans.
Rejuvenate Bio first to publish study showing that epigenetic reprogramming extends lifespan in 'normal' mice.
Rejuvenate Bio is Reversing Age-Related Diseases to Increase Healthspan.
Rejuvenate Bio raises $10M for gene therapy for aging in dogs and humans, co-founded by Harvard Medical School geneticist George Church.
Each quote is copied word for word and links to where it was posted. Promotion and off-topic posts are filtered out.
Frequently asked
Is Rejuvenate Bio trustworthy and reputable?
StartupHub's Data Trust & Reputation score for Rejuvenate Bio is 68 out of 100, a generally safe rating, based on site security posture, privacy practices, malware and phishing checks, and public reputation signals.
How much funding has Rejuvenate Bio raised?
Rejuvenate Bio has raised a total of $6M in funding. The most recent round on record is Financing.
How many employees does Rejuvenate Bio have?
Rejuvenate Bio has approximately 16 people on record.
Does Rejuvenate Bio have an affiliate program?
Yes, Rejuvenate Bio has an affiliate program. The program runs on Self-hosted affiliate. Register here: www.rejuvenatebio.com/affiliates
Public record
SEC filings, insider activity, nonprofit links and pay benchmarks for Rejuvenate Bio
